AzTrials
AzTrials

Radiation-Induced Fibrosis in Patients With Head and Neck CancerNCT04850170

The Evaluation of Manual Therapy for the Prevention of Radiation-Induced Fibrosis in Patients With Head and Neck Cancer

A study testing manual therapy and Speech therapy in people with Radiation-Induced Fibrosis in Patients With Head and Neck Cancer, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The subjects in this study are the patients with head and neck cancer after completion of the radiotherapy. Radiation-induced fibrosis is inevitable and there is no effective treatment to prevent it. Therefore, there are two parts in this study : The first part is a pilot study. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
manual therapy and Speech therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTaiwan
Study dates
1 Aug 2021to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age > 20 years
  • Head and neck cancer
  • After Completion of radiation therapy for 4 to 6 weeks
  • Be willing to accept manual therapy and long-term follow up

Who cannot join

  • Recurrence, metastatic cancer, or concurrent second cancer
  • With post-radiation dermatitis at neck or shoulder
  • Current pregnancy or lactation
  • Life expectancy of < 12 months.

Trial locations and contacts

1 site in 1 country.

Tsung-Hsien Yang, MD contact

886-975-362-728

cgupanda@gmail.com

Taiwan1 site, 1 recruiting
  • New Taipei Municipal Tucheng Hospital

    New Taipei City, 236

    TsungHsien Yang, 886-975-362-728, cgupanda@gmail.com

    Recruiting

Other trials in Taiwan

About this study

The subjects in this study are the patients with head and neck cancer after completion of the radiotherapy. Radiation-induced fibrosis is inevitable and there is no effective treatment to prevent it. Therefore, there are two parts in this study :

The first part is a pilot study. There will be 10 subjects included and manual therapy and rehabilitation will be arranged for 6 months. The manual therapy would be once a week at most, and the rehabilitation would be twice a week at most.

Read more

The second part is a randomized controlled study. 60 patients would be randomized divided into two groups. The group 1 is manual therapy(once a week at most) and rehabilitation(twice a week at most), and the group 2 is rehabilitation only(twice a week at most). Patients would be evaluated at baseline, 3rd, 6th, and 12th month. The evaluation is including the degree of superficial soft tissue fibrosis, numerical rating scale of pain, range of motion(neck), range of motion(shoulder), width of mouth opening, EORTC QLQ C30, EORTC QLQ H\&N 35, and functional oral intake scale. Besides, swallowing video fluoroscopy would be done at baseline, 6th, and 12th month.

When the subject completes the evaluation in the 12th month, the study is ended.

Because the radiation-induced fibrosis is progressed with time, we will follow up the condition of subjects at the next year and the following third year.

Being tested
manual therapy, Speech therapy
Keywords
Head and neck cancer, Post-radiation fibrosis, Manual therapy, Rehabilitation
Medical subject headings
Head and Neck Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • manual therapyProcedure or surgery

    1. release and stretch the muscles and fascia around shoulder girdle、upper arm and forearm;
    2. massage the masseter muscle and temporalis muscle;
    3. mobilization of the temporomandibular joint, the thoracic and cervical spine, shoulder, and elbow.
  • Speech therapyProcedure or surgery

    include the stretching of the neck, facial and oral movement training, and swallowing training

Study groups in NCT04850170
Study groupRoleWhat they receive
Experimental groupExperimentalThe first ten subjects will be enrolled in a pilot study. The following sixty subjects will be separated randomly to experimental group and control group. The first ten subjects and the experimental group will be arranged manual therapy and rehabilitation for six months.
Receives: Procedure: manual therapy; Procedure: Speech therapy
Control groupActive comparatorThe control group will be arranged rehabilitation.
Receives: Procedure: Speech therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline range of motion, neck at the 3rd month

    including neck flexion, extension, right and left lateral flexion, and lateral rotation

    Measured: baseline and 3rd month

  2. Change from Baseline Functional oral intake scales at 3rd month

    in this scales, the maximum values is grade seven, the minimum values is grade one. The higher scores mean a better outcome.

    Measured: baseline and 3rd month

Secondary outcomes (14)
  1. range of motion, shoulder

    to measure the degree of bilateral shoulder, including flexion, extension, abduction, adduction, external rotation, and internal rotation

    Measured: measure the range of motion at baseline, the 3rd month, the 6th month, the 12th month, the second year, and the third year

  2. Width of mouth opening

    measure the maximum interincisal opening and range of the jaw and mouth

    Measured: at baseline, the 3rd month, the 6th month, the 12th month, the second year, and the third year

  3. EORTC QLQ C30

    the most widely used questionnaire for cancer patients; explore aspects of quality of life assessment, evaluation and interpretation.

    Measured: at baseline, the 3rd month, the 6th month, the 12th month, the second year, and the third year

  4. EORTC H&N 35

    questionnaire for head and neck cancer patients.

    Measured: at baseline, the 3rd month, the 6th month, the 12th month, the second year, and the third year

  5. Numerical rating scale of pain

    evaluate the pain degree(0~10); higher scores mean a worse outcome

    Measured: at baseline, the 3rd month, the 6th month, the 12th month, the second year, and the third year

  6. Swallowing Video Fluoroscopy

    Observe that the patient swallows items with different thicknesses and textures via using a special real-time form of x-ray. This examination allows us to test the ability to swallow safely and effectively.

    Measured: at baseline, the 6th month, and the 12th month

  7. Change from Baseline range of motion, neck at the the 6th month

    including neck flexion, extension, right and left lateral flexion, and lateral rotation

    Measured: baseline and 6th month

  8. Change from Baseline range of motion, neck at the the 12th month

    including neck flexion, extension, right and left lateral flexion, and lateral rotation

    Measured: baseline and 12th month

  9. Change from Baseline range of motion, neck at the the 2nd year

    including neck flexion, extension, right and left lateral flexion, and lateral rotation

    Measured: baseline and 2nd year

  10. Change from Baseline range of motion, neck at the the 3rd year

    including neck flexion, extension, right and left lateral flexion, and lateral rotation

    Measured: baseline and 3rd year

  11. Change from Baseline Functional oral intake scales at 6th month

    in this scales, the maximum values is grade seven, the minimum values is grade one. The higher scores mean a better outcome.

    Measured: baseline and 6th month

  12. Change from Baseline Functional oral intake scales at 12th month

    in this scales, the maximum values is grade seven, the minimum values is grade one. The higher scores mean a better outcome.

    Measured: baseline and 12th month

  13. Change from Baseline Functional oral intake scales at 2nd year

    in this scales, the maximum values is grade seven, the minimum values is grade one. The higher scores mean a better outcome.

    Measured: baseline and 2nd year

  14. Change from Baseline Functional oral intake scales at 3rd year

    in this scales, the maximum values is grade seven, the minimum values is grade one. The higher scores mean a better outcome.

    Measured: baseline and 3rd year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2021
  2. Study start1 Aug 2021
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The subjects in this study are the patients with head and neck cancer after completion of the radiotherapy. Radiation-induced fibrosis is inevitable and there is no effective treatment to prevent it now. Therefore, there are two parts in this study : The first part is a pilot study. There will be 10 subjects included and manual therapy and rehabilitation will be arranged for 6 months. The manual therapy would be once a week at most, and the rehabilitation would be twice a week at most. The second part is a randomized controlled study. 60 patients would be randomized divided into two groups. The group 1 is manual therapy(once a week at most) and rehabilitation(twice a week at most), and the group 2 is rehabilitation only(twice a week at most).
Masking
None (open label)
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04850170
Sponsor's protocol ID
202002052A3
Other IDs
CMRPVVL0081
Status last verified
Apr 2021
First submitted
12 Apr 2021
Last updated
11 Mar 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wang B, Wei J, Meng L, Wang H, Qu C, Chen X, Xin Y, Jiang X. Advances in pathogenic mechanisms and management of radiation-induced fibrosis. Biomed Pharmacother. 2020 Jan;121:109560. doi: 10.1016/j.biopha.2019.109560. Epub 2019 Nov 15.

    PubMed 31739160
  • Purkayastha A, Sharma N, Sarin A, Bhatnagar S, Chakravarty N, Mukundan H, Suhag V, Singh S. Radiation Fibrosis Syndrome: the Evergreen Menace of Radiation Therapy. Asia Pac J Oncol Nurs. 2019 Jul-Sep;6(3):238-245. doi: 10.4103/apjon.apjon_71_18.

    PubMed 31259219
  • Hojan K, Milecki P. Opportunities for rehabilitation of patients with radiation fibrosis syndrome. Rep Pract Oncol Radiother. 2013 Aug 8;19(1):1-6. doi: 10.1016/j.rpor.2013.07.007. eCollection 2014 Jan.

    PubMed 24936313
  • Moloney EC, Brunner M, Alexander AJ, Clark J. Quantifying fibrosis in head and neck cancer treatment: An overview. Head Neck. 2015 Aug;37(8):1225-31. doi: 10.1002/hed.23722. Epub 2014 Jul 11.

    PubMed 24797251
  • Davis AM, Dische S, Gerber L, Saunders M, Leung SF, O'Sullivan B. Measuring postirradiation subcutaneous soft-tissue fibrosis: state-of-the-art and future directions. Semin Radiat Oncol. 2003 Jul;13(3):203-13. doi: 10.1016/S1053-4296(03)00022-5.

    PubMed 12903010
  • Raj VS, Pugh TM, Yaguda SI, Mitchell CH, Mullan SS, Garces NS. The Who, What, Why, When, Where, and How of Team-Based Interdisciplinary Cancer Rehabilitation. Semin Oncol Nurs. 2020 Feb;36(1):150974. doi: 10.1016/j.soncn.2019.150974. Epub 2020 Jan 16.

    PubMed 31955923
  • Krisciunas GP, Vakharia A, Lazarus C, Taborda SG, Martino R, Hutcheson K, McCulloch T, Langmore SE. Application of Manual Therapy for Dysphagia in Head and Neck Cancer Patients: A Preliminary National Survey of Treatment Trends and Adverse Events. Glob Adv Health Med. 2019 Apr 24;8:2164956119844151. doi: 10.1177/2164956119844151. eCollection 2019.

    PubMed 31041144
  • Krisciunas GP, Golan H, Marinko LN, Pearson W, Jalisi S, Langmore SE. A novel manual therapy programme during radiation therapy for head and neck cancer - our clinical experience with five patients. Clin Otolaryngol. 2016 Aug;41(4):425-31. doi: 10.1111/coa.12535. Epub 2016 Feb 8. No abstract available.

    PubMed 26381894

Questions about this trial

What is this clinical trial studying?

A study testing manual therapy and Speech therapy in people with Radiation-Induced Fibrosis in Patients With Head and Neck Cancer, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tsung-Hsien Yang, MD (886-975-362-728, cgupanda@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline range of motion, neck at the 3rd month (time frame: baseline and 3rd month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04850170, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in